The Covid-19 outbreak the world has gone through over the past two years showed how vulnerable our societies can be to pandemics and diseases. The Pasteur Network and the Rockefeller Foundation’s Pandemic Prevention Institute therefore decided to strengthen their partnership through the signature of a Memorandum of Understanding (MoU), sharing the common goal of detecting early and addressing infectious diseases.
Press Release:
Washington, D.C., Paris | July 26, 2022 – The Rockefeller Foundation’s Pandemic Prevention Institute (PPI) and the Pasteur Network have signed a Memorandum of Understanding (MoU) to advance early detection and reporting for emerging and re-emerging diseases and build a robust decentralized global surveillance network that strengthens local capacity for sharing high-quality data across countries. The collaboration aims to enhance the effectiveness of the Pandemic Prevention Institute and the Pasteur Network’s 33 member institutions in both addressing infectious diseases, such as COVID-19 and Monkeypox, and informing interventions against them.
“Our work with the Pasteur Network will undoubtedly make a transformational impact on global health security, leveraging the ability to advance equitable data-sharing practices that will provide key stakeholders and decision-makers with timely, more accurate and relevant information to make critical health and policy decisions,” said Dr. Rick Bright, CEO of The Rockefeller Foundation’s Pandemic Prevention Institute. “Our collective aim is to advance access to pathogen surveillance, genomic sequencing, analytics, and data sharing tools in low- and middle-income countries and to foster sentinel laboratory networks for early disease detection.”
“This MoU is a major milestone in our collaboration with The Rockefeller Foundation and the PPI that could lead to significant impact in epidemic and pandemic preparedness. Together, the Pasteur Network and PPI are an effective combination of complementary talents and capacity to address global health threats said Dr. Amadou Sall, President of the Pasteur Network.
“We are proud to support this initiative. This important, historic partnership will provide much-needed support to capacity building and epidemic intelligence,” said Professor Stewart Cole, President of the Pasteur Network Foundation that contributes to the Pasteur Network’s development.
Over the coming years, the partnership will focus primarily on the following areas:
· Advancing global equitable data sharing to provide key stakeholders and decision-makers with an analytical toolset that leverages timely, more accurate and relevant data and information,
· Bolstering epidemiological and genomic surveillance in low- and middle-income countries to track emerging pathogen variants and transmission for real-time analyses, as well as advancing access to pathogen surveillance and analytical tools, such as digital apps,
· Enhancing discovery of emerging and re-emerging high consequence pathogens, generating a diversity of essential disease surveillance data streams in areas such as zoonosis, anti-microbial resistance and water borne diseases and,
· Building fit for purpose data analytics and disease discovery and forecasting systems, informed by the organizations’ partner networks, that are relevant, sustainable, and equitable at the local, state, and pan-regional level.
The partnership will also focus on interdisciplinary research projects addressing the causes of outbreaks and epidemics. The combined networks will maintain local and regional structures to foster a permanent operational force and share technologies, systems, practices, and techniques with their networks.
>>> More information and Media contacts on the Pasteur Network website.